AI-generated summary
This study examined polarized light photobiomodulation with a Bioptron device in 30 patients with chronic skin or mucosal ulcers, treated over 12 weeks. The authors report that 60% of patients had a 50% reduction in lesion size at 2 months, and that pain and infection signs improved in most patients, though the study lacked a control group.
- Participants
- 30
- Who or what was studied
- 30 patients (19 women, 11 men) with chronic cutaneous or mucosal ulcerative lesions
- Limits stated in the abstract
- The abstract describes an uncontrolled study with a small sample, and 20 patients were analyzed for symptoms, histology and ulcer characteristics.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Visual analogue scale, Wound healing, Nitric oxide. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.